Dr. Suzanne Hartford is a highly
accomplished scientist with a strong
background in genetics and
developmental biology. She received
her Ph.D. from Cornell University in
2012, where she studied the underlying
mechanisms of genetic diseases. Dr.
Hartford's most recent role is at
Regeneron Pharmaceuticals where she
joined as a Staff Scientist and
quickly rose through the ranks to
become a Senior Principal Scientist.
In this role, she has led numerous
projects focused on understanding and
developing treatments for genetic
disorders, along with gaining
experience in CRISPR, gene therapy,
and non-viral delivery vehicles (LNP).
Before joining Regeneron, Dr. Hartford
was a CRTA Postdoctoral Fellow at the
National Cancer Institute, where she
conducted research on the role of
genetic mutations in cancer
development (BRCA2 variants of unknown
significance). She also gained
valuable experience as a Research
Assistant at The Jackson Laboratory,
where she worked on projects related
to mouse genetics. Throughout her
career, Dr. Hartford has published
numerous research articles in top
scientific journals and has presented
her work at conferences. She is known
for her expertise in genetic
engineering techniques and her ability
to effectively lead and collaborate
with multidisciplinary teams. In
addition to her scientific
achievements, Dr. Hartford is also
passionate about mentorship and has
served as a mentor to undergraduate
and graduate students. She is
dedicated to advancing the field of
genetics and is committed to finding
new treatments for genetic diseases.